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a b s t r a c t
Preclinical evaluation in a small animal model would help the development of gene therapies and
vaccines based on foamy virus vectors. The establishment of persistent, non-pathogenic infection with
the prototype foamy virus in mice and rabbits has been described previously. To extend this spectrum of
available animal models, hamsters were inoculated with infectious cell supernatant or bioballistically
with a foamy virus plasmid. In addition, a novel foamy virus from a rhesus macaque was isolated and
characterised genetically. Hamsters and mice were infected with this new SFVmac isolate to evaluate
whether hamsters are also susceptible to infection. Both hamsters and mice developed humoral
responses to either virus subtype. Virus integration and replication in different animal tissues were
analysed by PCR and co-cultivation. The results strongly indicate establishment of a persistent infection
in hamsters. These studies provide a further small animal model for studying FV-based vectors in
addition to the established models.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Foamy viruses are complex retroviruses that are presently the
only known members of the genus Spumavirus. Spumaviruses
have been isolated from several mammals, particularly horses,
cats, cattle, non-human primates and apes, with a high prevalence
in adult captive primates. Despite long periods of persistent
infection, no signs of disease or pathological changes have ever
been observed (Blewett et al., 2000; Falcone et al., 2003;
Schweizer et al., 1995). Today, it is generally agreed that humans
are not a natural host for foamy viruses (Heneine et al., 1998;
Herchenroder et al., 1994). Furthermore, disease has never been
observed in any of the known cases of zoonotic transfer of SFV to
humans (Boneva et al., 2007). This makes foamy viruses interest-
ing candidates for the development of vector systems for gene
therapy (Erlwein and McClure, 2010). In addition, the life-long
chronic infection of the host offers an advantage for the develop-
ment of novel vaccines able to induce a persistent, targeted and
effective stimulation of the immune system using replication-
competent vaccine viruses.
There are basically two small animal models currently available
for studying foamy virus infection. The ﬁrst involves intraperitoneal
(i.p.), intradermal or intranasal (i.n.) inoculation of rabbits with SFV-
infected cell culture supernatant, which leads to a persisting infec-
tion that can be detected for at least 264 days by co-cultivating cells
from various organs (Swack and Hsiung, 1975). In one experiment,
an immune response to viral antigens could be demonstrated ﬁve
years after infection (Saib et al., 1997). The second model involves
SFVcpz infection of mice, demonstrated by virus re-isolation and
detection of speciﬁc antibodies. Brown et al. (1982) showed virus
replication in the spleen and kidneys, although as time progressed
this replication became increasingly difﬁcult to demonstrate. In later
experiments it was possible to demonstrate virus replication in
various mouse strains by detection of provirus by PCR and the
measurement of an SFVcpz(hu) speciﬁc immune response, although
virus re-isolation was successful in only a few cases (Schmidt et al.,
1997b). Again, infectionwas not associated with any obvious signs of
disease. However, some studies have suggested an immunosuppres-
sive effect during the initial phases of an SFVcpz(hu) infection of
rabbits and mice that was subsequently compensated for by the
immune system as the study progressed (Hooks and Detrick-Hooks,
1979; Santillana-Hayat et al., 1993) although no other effect on the
animal's health was observed and the immunological changes
cleared over time. Transgene mice that permanently express FV
antigens in all cells do show damage to the central nervous system
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and striated muscle (Aguzzi et al., 1996). Although this highly
artiﬁcial situation suggests a pathogenic potential for foamy virus
antigens when expressed at high levels, such effects have never
been seen in infected natural hosts or in the documented cases of
zoonosis.
This paper describes a new small animal model for studying
foamy virus infection in vivo that uses Syrian golden hamsters. The
hamster was long ago reported to be a natural host for foamy
viruses (Hruska and Takemoto, 1975) although there are no later
publications conﬁrming the existence of a hamster foamy virus,
which calls the initial report into question. Certainly, no evidence
(by serology, PCR or co-cultivation) for a pre-existing natural
infection could be found in the Syrian golden hamsters (Charles
River, Sulzfeld, Germany) involved in the study presented here.
We could, however, show that Syrian golden hamsters are
susceptible to infection with a range of different foamy virus isolates.
Furthermore, we describe a novel method of foamy virus infection
involving inoculation of the animals via gene gun with a puriﬁed
molecular clone of the PFV genome. The development of the anti-
body response to viral antigens during the early phase of infection is
described and the new hamster model is compared to the currently
established mouse model.
Results
Inoculation of animals with PFV
To facilitate the study of the foamy virus infection in vivo we
attempted to establish a new small animal model using Syrian
golden hamsters. Hamsters and C57BL/6 mice were inoculated in
parallel to allow the new model to be compared with the
published mouse model (Schmidt et al., 1997b). The molecular
clone pHSRV2/13 (kindly provided from Martin Löchelt, DKFZ
Heidelberg) used here for the infection studies contains a deletion
in the U3 region but has replication characteristics similar to those
of a comparable wild-type virus. Its use also allows a direct
comparison to be made with the results from previous publica-
tions that have predominantly used this variant (Nestler et al.,
1997; Saib et al., 1997; Schmidt and Rethwilm, 1995), including
that of Schmidt et al. (1997b) describing the mouse model.
In addition, inoculation with naked plasmid DNA via gene gun
(GG) was compared with the usual method that uses infectious
cell culture supernatant. Initiation of infection using DNA is a
relatively novel technique that offers a number of advantages (e.g.
genetic stability, no contamination with cell culture material, good
Fig. 1. (a) Development of PFV-speciﬁc antibodies in hamsters following gene gun inoculation of 3 mg pHSRV2/13 DNA. (b) Development of PFV-speciﬁc antibodies in
hamsters following inoculation of 106 infectious PFV particles. PFV-infected BHK-21 cell lysate was used to coat the ELISA plates. Sera were diluted in three-fold steps from
1:20 to 1:43,740 and the titre calculated as the dilution at which the best-ﬁt curve intercepted the cutoff OD (0.2). (c) Western blot of PFV-speciﬁc antibody development in
hamster H17/3 (infected by gene gun DNA delivery). PFV-infected BHK-21 cells lysed with RIPA-buffer were used as antigen and sera were diluted 1:750. In order to recognise
the processing of the Gag precursor (p70.6 kDa) into p68 Gag, the relevant region of the blot (indicated in the size ladder by arrows) is shown enlarged. The right box shows
the PFV-Gag double bands and lower Bet band from lane 4. No cross-reaction could be detected against BHK naive lysate (NK). The putative PFV-protein bands p70/68 Gag,
p60 Bet and p36 Tas (Lindemann and Goepfert, 2003) are labelled. (d) Development of PFV-speciﬁc antibodies in mice following gene gun inoculation of PFV-DNA. ELISAs
were performed as described above.
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reproducibility) over traditional methods and has been used to
initiate infection (Kent et al., 2001). DNA corresponding to the
foamy virus molecular clone pHSRV2/13 (Löchelt et al., 1991;
Schmidt et al., 1997a) was inoculated by gene gun into the upper
epidermis. To allow a direct comparison with the standard method
of inoculating infectious virus particles, a group of four hamsters
was inoculated i.p. with 1 ml cell culture supernatant contain-
ing approximately 106 infectious PFV particles. The animals were
inspected every day for external signs of pathology and other signs
of disease but no such symptoms were observed during the course
of the study.
Development of antibody responses to PFV in hamsters and mice
Retrobulbar blood samples were taken from hamsters and mice
over a period of 148 days post inoculation [d.p.i.]. Serum IgG
speciﬁc for PFV proteins was detected by ELISA and western blot.
Lysates of PFV-infected and uninfected BHK-21 cells were used as
antigen. Fig. 1 a, b and d shows the development of PFV-speciﬁc
antibodies after inoculation as measured by ELISA. Hamsters
inoculated with puriﬁed PFV-DNA showed no signs of a humoral
immune response in the ﬁrst 35 days following application of the
DNA but a continuous increase in responses from this time point
until day 92 (Fig. 1a). This was followed by a temporary drop in
antibody levels as measured on day 127 before a recovery or even
increase in levels thereafter. This pattern of reactivity suggests a
persisting infection with possible repeating phases of viraemia.
The ELISA data could be conﬁrmed by western blot. Fig. 1c shows,
for example, the antibody response to the typical PFV antigens in
hamster 17/3 over time. No reactivity can be seen on days 20 and
35 after inoculation, with the ﬁrst positive signals (to the viral Gag
and Bet proteins) being seen on day 50 and increasing in the
subsequent samples. The p70/p68 double band typical for foamy
viruses (area indicated by arrows) is shown enlarged in Fig. 1c
(right box, top) as the small difference in molecular weight causes
the two bands to run very close to each other. The bands below the
double bands probably represent the p60 Bet protein. The viral
proteins Gag, Bet and Tas have been labelled according to the
calculated molecular weights. The remaining bands presumably
represent the proteins gp170Env-Bet, gp130Env, gp80SU and
gp48TM (Lindemann and Goepfert, 2003). Bet and Gag appear to
be the immunodominant proteins, inducing in the early stages the
strongest immune responses. The speciﬁcity of the immune
responses observed is demonstrated by the lack of binding using
pre-immune serum (Day 0) and the lack of response to uninfected
BHK-21 cell lysate (NK). The other animals in the group showed
similar patterns of western blot activity (data not shown).
To address the possibility that the immune responses observed
in hamsters were simply the result of ‘genetic immunisation’ (i.e.
through expression of viral proteins from inoculated DNA without
infection) we constructed a replication-deﬁcient HSRV2/13 viral
genome by deletion of the complete bel2-ORF including the 30
polypurine tract in front of the 30LTR. After conﬁrming lack of
infectivity in cell culture, a group of four hamsters was inoculated
via gene gun. Blood samples were taken over a period of 105 days
and sera subjected to ELISA. As shown in Fig. 2 of the supplement,
antibodies speciﬁc for PFV were not detected.
The development of PFV-speciﬁc antibodies in hamsters inocu-
lated with virus-containing cell culture supernatant is shown in
Fig. 1b. The pattern of reactivity is clearly different than that seen
with inoculation via DNA, indicating possible differences in the
initial infection. Sera from three of the four animals contained
PFV-speciﬁc antibodies at 20 days post inoculation that peaked at
35–50 days and then remained constant or diminished thereafter.
Animal H22/1 remained seronegative by ELISA and western blot
(WB data not shown).
The development of PFV-speciﬁc antibodies in mice inoculated via
gene gunwas also measured by ELISA (Fig. 1d). In contrast to the DNA-
inoculated hamsters, the mice generally showed signs of a humoral
immune response at 22 days post inoculation. These levels peaked
between 51 and 107 days and by day 148 antibodies in all animals
were decreased. However, the antibody levels were generally much
higher compared to the hamster sera. One mouse (4/2) showed a
weaker reaction to PFV inoculation. These data suggest that, in C57BL/
6J mice, DNA-inoculation with PFV stimulates the immune system
differently than in hamsters. The stronger immune response may
result in amore vigorous suppression of viraemia leading to a decrease
in antibody levels as antigenic stimulation wanes.
Isolation and characterisation of a new SFVmac isolate from
rhesus macaques
We tested next the replication competence of additional
primate foamy virus strains in these animals. A new strain of
SFVmac was isolated from a rhesus macaque housed at the Paul
Ehrlich Institute (Langen, Germany). Fresh PBMC were co-
cultivated with BHK-21 cells and after three weeks the typical
cytopathic effect (CPE) was observed in the cell culture. In order to
precisely characterise the newly isolated virus strain, the complete
genome was sequenced and compared with those of other known
foamy viruses. The ORFs for Gag, Pol and Env as well as the ORF1
and ORF2 for the accessory proteins Tas and Bet agree with those
described by Kupiec et al. (1991) for the published SFV1 isolate
(NCBI: X54482.1). The isolated virus could be shown to clearly
belong to the SFVmac class, albeit with a divergence of 12% from
the published sequence. The individual open reading frames of the
viral genome were also compared to the sequences of the SFV1
and PFV (HSRV2) isolates described above and the theoretical sizes
of the precursor proteins calculated (Table 1). It is presently not
possible without further investigation to draw any conclusions
concerning the processing of the individual proteins. However, the
sequences do contain protease cleavage sites typical for foamy
viruses, suggesting a corresponding form of processing. The new
isolate was named SFVmac-R289hybAGM and the sequence sub-
mitted under reference number JN801175.1 to the NCBI. Interest-
ingly, a closer analysis of the Env ORF sequence reveals an anomaly
that was also present in an SFVmac isolate stored at ATCC (Galvin
et al., 2013). A higher divergence was found in the SU region of the
new isolate (less than 60% homology between amino acids 242
and 505 of Env). A new analysis concentrating on this region
revealed a 76% homology at the amino acid level with a simian
foamy virus strain of the AGM class (Schweizer et al., 1999). For
this reason, the isolate was termed ‘hybrid AGM’. It is possible that
this virus was newly formed by recombination in a host cell
superinfected with two distinct viruses. Such a recombination in
the envelope gene has been recently described (Galvin et al.,
2013). A detailed analysis of the precise characteristics of the
newly described virus and the impact of the presumed recombi-
nation event will be carried out in the future. Initial in vitro studies
do, however, indicate an advantage with regard to replication
efﬁciency (data not shown).
Development of SFVmac-R289hybAGM speciﬁc antibodies
in hamsters and mice
The isolated SFVmac was then characterised in vivo. As the new
virus was not available as a recombinant DNA genome at the time of
starting the experiment, it was not possible to infect animals by gene
gun. The groups of mice and hamsters were therefore each inocu-
lated intraperitoneally with 1 ml of cell culture supernatant contain-
ing approximately 106 infectious SFVmac-R289hybAGM particles.
Throughout the study, blood samples were taken regularly and the
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sera tested for SFVmac-speciﬁc antibodies using the established
ELISA. As one hamster died during the initial blood sampling, it was
only possible to obtain data for three animals of the SFVmac group.
The results from the infected hamsters are shown in Fig. 2a. SFVmac
speciﬁc antibodies were ﬁrst detected shortly after the inoculation,
indicating a strong initial infection. The responses increased steadily
thereafter reaching an initial peak on day 92 before showing a
sudden drop and subsequent recovery. This pattern of reactivity
again suggests a persistent infectionwith viraemic phases. The ELISA
data for the three animals could be conﬁrmed by western blot.
Fig. 2c shows, for example, the clear increase in the levels of
antibodies from animal 14/3 able to bind to viral antigens inwestern
blot. Speciﬁc antibodies were ﬁrst detected after 16 days. Speciﬁcity
of the immune responses observed is demonstrated by the lack of
binding of pre-immune serum (Day 0) and the lack of response to
uninfected BHK-21 cell lysate. An additional western blot was
performed to conﬁrm the speciﬁcity of the antibodies. Sera from
the ﬁnal bleed of hamsters 14/1 and 14/3 were tested against
uninfected and SFVmac infected BHK-21 cell lysates (Fig. 2d).
No reaction with uninfected BHK cells was observed. A further
speciﬁcity control with secondary antibody alone was also negative
with both cell lysates. However, the separation of the p69/p66 Gag
double band (area indicated by arrows) was very difﬁcult to
distinguish and this part of the blot is therefore shown enlarged.
The bands p57 Bet and p35 Tas were also labelled. Classiﬁcation of
the addition bands is, due to the novelty of the isolate, presently not
possible and will be the subject of future studies. To compare the
Table 1
Predicted molecular weights of SFVmac-R289hybAGM precursor proteins (without
glycosylation) and sequence homology to other foamy viruses.
SFVmac-R289hybAGM LTR Gag Pol Env Tas Bet
kDa – 68.9 130.1 112.8 35.1 57.4
SFV1a 89% 88% 96% 82% 82% 79%
PFVb 81% 47% 79% 68% 39% 37%
a Indicates homology at the DNA level between SFVmac-R289hybAGM and
SFV1 sequence (NCBI: X54482).
b Indicates homology at the DNA level between SFVmac-R289hybAGM and the
PFV sequence (HSRV2; NCBI: Y07724).
Fig. 2. (a) Development of SFVmac-R289hybAGM speciﬁc antibodies in hamsters following inoculation with 106 infectious particles. R289hybAGM-infected BHK-21 cell
lysate was used to coat the ELISA plates. Sera were diluted in three-fold steps from 1:20 to 1:43,740 and the titre calculated as the dilution at which the best-ﬁt curve
intercepted the cutoff OD (0.2). (b) Development of SFVmac-R289hybAGM-speciﬁc antibodies in mice following inoculation with 106 infectious particles. ELISAs were
performed as described above. (c) Western blot of SFVmac-speciﬁc antibody development in hamster H14/3. SFVmac-R289hypAGM-infected BHK-21 cells lysed with RIPA-
buffer were used as antigen and sera were diluted 1:750. No cross-reaction could be detected against BHK naive lysate [NK]. (d) Western blot control for the speciﬁcity of IgG
developing in the SFVmac infected hamster compared to the response of the macaque from which the virus was originally isolated. Sera from the SFVmac infected hamster
were tested on uninfected BHK-21 [B()] and SFVmac infected BHK-21 lysates [B(þ)] at a serum dilution of 1:1000. No cross-reaction of the secondary antibody with the cell
lysate was observed (lanes 5 and 6). The small box shows an enlargement of the SFVmac Gag double-band from lane 3 (indicated by arrows in the MW ladder). The putative
bands for p69/p66 Gag, p57 Bet and p35 Tas (Lindemann and Goepfert, 2003) are labelled. The IgG response of the naturally infected rhesus macaque 289 to SFVmac proteins
is shown on the right. No cross-reactivity to uninfected BHK-21 lysate could be detected. Sera were diluted 1:1500 .
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immune response with that of the natural host, the antibody
response of the animal from which the virus was originally isolated
was tested using infected and uninfected cell lysates (Fig. 2d, right).
Despite the monkey having a stronger reaction, the similarity in the
pattern of bands suggests a comparable immune response. The lack
of reactivity with uninfected BHK-21 cell lysate again conﬁrms
speciﬁcity. Fig. 2b shows the development of speciﬁc antibodies in
the infected mice. Unfortunately, two of the animals died during the
blood sampling on day 51, leaving only three to complete the study.
To avoid further loss of animals, sampling was restricted to a ﬁnal
bleed on day 148. Similar to the situation with the PFV-DNA
inoculated mice, a speciﬁc response was seen during the initial
phase of infection. The drop in antibody response at the end of the
experiment is also similar to that seen in PFV inoculated mice, again
indicating different courses of infection in mice and hamsters. This
late loss of antibodies was conﬁrmed by western blot in which only
weak bands at the level of p69/p66 Gag and p57 Bet were visible
(data not shown).
Neutralising antibody responses in rhesus macaques and hamsters
An assay to evaluate the ability of FV-speciﬁc antibodies to
neutralise virus infectivity was developed and used to test sera from
naturally infected macaques and inoculated hamsters (Fig. 3 of the
supplement). In comparison to the long-term infected rhesus mon-
keys, only a relatively weak neutralising effect could be demonstrated
in the hamsters. Sera from all naturally infected rhesus macaques,
when diluted 1:20, showed almost 100% neutralisation of SFVmac.
Indeed, two macaques showed strong cross-neutralisation of PFV,
whereas the other two animals had type-speciﬁc neutralising activity.
As sera from the hamster group inoculated with replication-
incompetent HSRV2/13 (group H3) showed no neutralising activity,
the effect would appear to be speciﬁc. No cross-reactivity between the
groups of inoculated hamsters was observed.
At the time of blood sampling, the rhesus macaques were at
least two years SFV-positive, and probably much longer. This could
account for the signiﬁcantly higher titres and cross-reactivity. In
addition, the difﬁculties in isolating virus from experimentally
infected animals indicates that virus loads in hamsters and mice
are much lower than in the natural host and this could result in
weaker immune responses. The induction of neutralising antibo-
dies nevertheless provides further evidence for a productive
infection.
Re-isolation of PFV and SFVmac from hamsters and mice
Attempts to demonstrate virus replication in selected organs
were made at the end of the infection studies at 148 d.p.i. Lungs
and spleens of animals inoculated with SFVmac supernatant or via
gene gunwith PFV-DNA were removed and processed to yield single
cell suspensions that were co-cultivated with MRC-5 cells. Because
virus re-isolation using species-homologous cells can be inhibited by
the release of gamma-interferon from infected blood cells (Falcone
et al., 1999b), we always used species-mismatched cell lines for the
co-cultures. Furthermore, the oral and nasal cavities of hamsters and
mice were washed out with PBS that was then added to MRC-5 to
check for viral replication in the oral mucosa. Co-cultures with lung
cells from hamsters 14/1 and 14/4 showed typical CPE after two
weeks incubation. Four days later, the spleen co-cultures from
hamster 14/1 were also positive. The lung co-cultures from hamster
14/3 became positive after three weeks. The co-culture experiments
were stopped after four weeks, the cells were lysed and the presence
of proviral DNA tested by SFVmac- and PFV-speciﬁc PCR (Table 2). All
cultures that showed CPE also tested positive for SFVmac provirus.
Mouse organs tested negative for SFVmac and all PFV inoculated
animals tested negative for provirus. Similarly, all co-cultures with
mucosal washes remained negative for CPE and provirus.
Detection of proviral DNA in the organs of PFV and SFVmac infected
animals by nested PCR
In addition to the co-culture experiments, the individual organs
were tested for the presence of proviral DNA as evidence for
productive infection. A nested PCR was developed that detected
proviral DNA in the SFVmac/PFV integrase region and this was
used to test genomic DNA isolated from the gut, lungs, liver, lymph
nodes, spleen, tongue and blood of the test animals. Proviral DNA
in 1 mg genomic DNA (equivalent to approximately 1.6105 cells)
was only detected in the blood cells of three SFVmac infected
hamsters (data not shown). All other samples tested negative.
Discussion
Earlier studies had shown that rabbits and mice can be infected
with various strains of foamy virus (Hooks and Detrick-Hooks,
1979; Saib et al., 1997; Swack and Hsiung, 1975). These animals
were therefore used to establish animal models for artiﬁcial foamy
virus infection. This publication presents a new small animal
model using hamsters for the in vivo characterisation of foamy
virus infection.
Our infection experiments included a comparison between
the use of pure DNA to inoculate animals and the usual method
of inoculating with infected cell culture supernatant. In our
opinion, using a full-length clone for inoculation has a number
of advantages, the major of which is the fact that a plasmid DNA
preparation is virtually 100% free of cell culture components such
as virus-opsonised cell-surface proteins, unclassiﬁed virus strains
or mycoplasma. In addition, we could show that this route of
application yielded a high rate of infection. Our preliminary
experiments in which hamsters and mice were inoculated with
PFV-DNA by gene gun also gave a 100% infection rate (10 out of 10,
data not shown) whereas inoculation with virus-containing super-
natant resulted in a number of failures to infect. The ELISA and
western blot data indicate, in addition, that gene gun inoculation
stimulated a different pattern of immune response in the ham-
sters. This may be due to the fact that the initial inoculating dose is
very low compared to the i.p. inoculation with 106 particles.
Following DNA inoculation, virus replication and release in trans-
duced epithelial commences at a very low level. This is similar to
the situation following natural infection because the initial trans-
mission through biting or scratching is also likely to involve a few
virus particles only. In addition, the storage and transport of gene
gun ammunition is far simpler, a factor that could be important if
recombinant replicating foamy viruses were to be used as vaccine
vectors. However, the initial costs of purchasing gene gun equip-
ment are, of course, relatively high.
Table 2
PFV and SFVmac-R289hybAGM re-isolation from saliva, lung- and spleen-cells.
Hamsters Mice
PFVa SFVmacb PFVa SFVmacb
Saliva 0/4 0/3 0/5 0/3
Lung 0/4 3/3 0/5 0/3
Spleen 0/4 1/3 0/5 0/3
a Animals were inoculated with 3 mg HRSV2/13 (PFV) DNA via gene gun (mouse
group M4 hamster group H17).
b Animals were inoculated with 1ml SFVmac-R289hybAGM (106 infectious
particles) containing supernatant (mouse group M1, hamster group H14).
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It was possible to demonstrate the induction of a speciﬁc
immune response in hamsters following inoculation with plasmid
DNA coding for the PFV deletion U3-mutant HSRV2/13. Inoculation
of mice in parallel allowed a direct comparison between the new
hamster model and the established mouse model (Fig. 1). Using
the newly established ELISA, speciﬁc antibodies appeared in
hamsters at around 50 d.p.i. with a continuous increase in titre
until day 92 and a partial drop and rebound in the last two
bleedings. As this pattern was seen in all four infected hamsters, it
might indicate a transient control of viraemia similar to that seen
for other retroviruses such as equine infectious anaemia virus
(Olsen, 1998), although this has so far not been shown for foamy
viruses. To rule out the possibility that the immune responses
observed were simply induced by DNA-immunisation via gene
gun (Niederstadt et al., 2012; Siegismund et al., 2009), control
experiments using a replication incompetent HSRV2/13 mutant
were carried out. PFV-speciﬁc antibodies were not induced in any
hamsters inoculated with this construct (supplement, Fig. 2.).
Furthermore, the plasmids used the foamy virus LTR as promoter,
which is activated exclusively by the spumavirus transactivator
(Tas) (Erlwein and Rethwilm, 1993). A promoter-driven gene gun
effect is therefore unlikely.
The pattern of antibody response was different in the mice,
with four of ﬁve animals developing speciﬁc antibodies by 20 d.p.i,
plateauing much higher than in the hamsters after 50 days and
with no transient reduction in titre (shown in Fig. 1). This suggests
a different course of foamy virus infection in the mice, with the
drop in antibody response in all animals by the last bleeding
suggesting a cessation of viral replication. It is possible that the
strong immunological response to the infection cleared most of
virus producing cells and the on-going virus release was either
delayed or abrogated. Previous studies have demonstrated an
immune response in BL/6 mice for as long as 24 weeks after
infection (Schmidt et al., 1997b). This suggests a persistent and
long lasting infection in mice. Whether or not the pattern of
replication in the two species really does signiﬁcantly and repro-
ducibly differ should be clariﬁed in further experiments.
In addition to the inoculation of full-length foamy virus
genome by gene gun, a group of hamsters was also inoculated in
parallel with infectious PFV cell supernatant. Although three of the
four animals became seropositive by 20 d.p.i. with high antibody
levels and a decrease in titre over time (compared to 45 days
following DNA inoculation), one animal remained seronegative
throughout the period of study, suggesting a failure to infect
(shown in Fig. 1b). These ﬁndings could reﬂect the high number
of virus particles in the initial inoculum. The strong immune
response could result from a rapid establishment of high-level
viral infection, a scenario not occurring during natural low level
exposure. In this study, at least, PFV-DNA inoculation proved to be
a more reliable method of infection.
Infection of cats with the feline foamy virus (FFV) is an
additional animal model that has been characterised in detail
(Alke et al., 2000; Schwantes et al., 2003). This system has the
advantage of being based on a naturally occurring virus/host
system in contrast to those based on the use of rodents. However,
in contrast to the almost ubiquitous use of rodents, most labora-
tories do not have the capacity for housing cats, and an FFV/rodent
model could be useful in these cases. A group of four Hamsters
was therefore inoculated by gene gun with DNA (pCF-7, kindly
provided from Martin Löchelt, DKFZ Heidelberg) coding for the
feline foamy virus. A western blot with FFV-infected cell lysate
showing the immune response 78 days after inoculation is
provided in the supplement Fig. 1. Three of four animals show a
double band around 50 kDa. We suggest this could be the FFV Gag
double band p51/p48. However, a number of unspeciﬁc bands also
appear in this blot. In contrast to the experiments using PFV-DNA,
the FFV construct included the relatively strong CMV-EI promoter
in place of part of the 50-LTR (Schwantes et al., 2002), which means
that an immune response to expressed proteins without infection,
i.e. by ‘DNA-immunisation’ (Davis, 1997; Nguyen-Hoai et al., 2012;
Witkowski et al., 2009), cannot be ruled out. However, the
maintenance of the immune response for 165 days following
inoculation indicates that the hamsters were indeed productively
infected with FFV. An unequivocal veriﬁcation of these results and
determining whether or not the hamster model presented here
provides a useful tool for evaluating FFV-based vectors will require
additional studies.
In order to extend the range of foamy virus subtypes suitable for
infection studies in hamsters, we carried out a series of infection
studies using an SFVmac isolate. A number of studies have shown that
circulating blood lymphocytes represent a major in vivo reservoir for
foamy viruses and that the virus can be isolated from these cells by
in vitro co-cultivation (Tobaly-Tapiero et al., 2005; von Laer et al., 1996).
Cultivating one million PBMCs from an infected rhesus macaque with
BHK-21 cells resulted in the successful recovery of a novel primary
isolate of SFVmac. This wild-type strain was sequenced to facilitate
classiﬁcation and homology analyses. Due to the obvious differences to
the published sequence, the new isolate was given the designation
‘SFVmac-R289hybAGM’, as it appears to have been formed by the
recombination of two separate viral species. Recently, work has been
published that demonstrates a similar recombination event an isolate
of SFVmac deposited with ATCC (Galvin et al., 2013). This conﬁrms our
observation and makes it unlikely to be the result of a laboratory
artefact. These ﬁndings also suggest a potential ‘hotspot’ for recombi-
nation events in the receptor binding domain of the foamy virus
surface glycoprotein. This would certainly appear to warrant further
investigation.
Hamsters and mice were inoculated intraperitoneally with
infectious cell culture supernatant containing the new isolate.
However, attempts to re-isolate virus or demonstrate proviral DNA
by PCR only succeeded in the three hamsters infected with
SFVmac-R289hybAGM. Lung tissue from all three of these animals
and spleen cells from one animal yielded virus upon co-culture.
In contrast, attempts to isolate virus from the organs of the
SFVmac infected mice failed, indicating a lower level of virus
replication or a stronger immune response in this species. This is
also indicated by high antibody titres in the initial infection and
the following drop in antibody titres over time to low levels.
It was also not possible to isolate virus from PFV-DNA inocu-
lated animals (hamsters or mice), which is in agreement with
previous studies (Schmidt et al., 1997b) in which re-isolation of
PFV was only possible in 2 of 52 cases. Proviral DNA could only be
detected by PCR in the PBMC of the three SFVmac infected
hamsters, indicating that these cells are indeed a reservoir for
foamy virus during this phase of infection, in agreement with
observations in the natural host species (von Laer et al., 1996).
Samples of saliva from none of the rodents infected here yielded
infectious virus, which is in contrast to situation in naturally
infected primates in which virus replication and release of viral
particles has been demonstrated (Falcone et al., 1999a; Falcone
et al., 2003). Based on the fact that we failed to detect viral DNA
in the lung or spleen cells of SFVmac inoculated hamsters but
could re-isolated virus from the same tissues, it would appear that
re-isolation is the more sensitive method for detecting virus
replication in animal tissues. As it is possible, in principle at least,
to detect one infected cell in ﬁve million, a level of sensitivity
very difﬁcult to achieve by PCR, this is perhaps not surprising. The
failure to re-isolate or detect PFV by PCR in all animal tissues may
therefore reﬂect a genuinely very low level of replication in vivo.
We did observe a replication advantage of SFVmac-R289hybAGM
over PFV in vitro (data not shown), which could explain the
differences in replication efﬁciency in vivo. However, the pattern
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of antibody development strongly suggests that, despite the lack of
detectable PFV in experimental animals, a productive infection via
gene gun inoculation or supernatant infection had occurred.
Speciﬁc antibodies were detectable over period of nearly 150 days
and the increase in antibody titres between day 127 and 148 in
both hamster groups (Fig. 1a and Fig. 2a) indicates an on-going
viraemic phase of infection and persistent replication. The induc-
tion of neutralising antibodies nevertheless provides further
evidence for a productive infection.
The development of FV-based vectors has clearly advanced in
the recent years. However, evaluation of such vectors in primates,
although ideal, poses many problems. In addition to the high costs
both in terms of animals and infrastructure associated with
primate studies, the availability of FV-negative animals is severely
limited. Although the relevance for clinical use of immunological
data obtained in small animal models is itself often questionable,
these often provide an invaluable ﬁrst step in the evaluation
of such vectors. Our results demonstrate that, particularly for
SFVmac, the replication in hamsters is clearly different from that
in mice. The hamster model presented here therefore provides a
further small animal system that facilitates a broader evaluation.
In summary, the small animal model presented here using the
Syrian golden hamster introduces a relatively cost-effective, sim-
ple and reproducible tool for investigating foamy virus infection
and recombinant vector systems in vivo that should be useful for
studies in the future.
Methods
Foamy virus isolation and production of infectious cell culture
supernatant
The primary isolate SFVmac-R289hybAGM was obtained by
co-cultivating 2106 PBMC from rhesus macaque 289 (Paul
Ehrlich Institute) with BHK-21 cells in RPMI containing 10% FCS,
1% penicillin/streptomycin, 180 U/ml human IL-2 and 40 mg/ml PHA
(Sigma Aldrich, Germany). After two weeks, the cells exhibited the
cytopathic effect typical of foamy virus infection and cell-free
supernatant was collected. DNA was isolated from the infected cells
and the viral genome was ampliﬁed in sections by PCR for
sequencing. Infectious cell culture supernatant for animal inocula-
tion was obtained by transfecting BHK-21 cells with full-length
genomic DNA of the HSRV2/13 strain of foamy virus (Schmidt et al.,
1997a) and the SFVmac viral stock was obtained by infecting BHK-
21 cells with the primary viral stock of SFVmac R298hybAGM. After
two weeks the supernatants were ﬁltered to remove cells, aliquoted
and frozen in liquid nitrogen until use. Infectious titres were
determined by endpoint dilution in BHK-21 cultures and detection
of proviral DNA in cell lysates 72 hours later by real-time PCR.
Experimental infection of hamsters and mice with PFV/SFVmac
by gene gun and by inoculation with infectious supernatant
Hamsters and mice were obtained from Charles River Inc.
(Sulzfeld, Germany). Inoculation via gene gun was achieved using
gold particles coated with the DNA. Brieﬂy, viral DNA of the
molecular clone pHSRV2/13 was coated onto gold particles (0.8–
1.5 mm, Alfa Aeser GmbH & Co KG (Karlsruhe, Germany), according
to the manufacturer's instructions using the Tubing Prep Station
(Bio-Rad, Munich, Germany). The coated particles were then deliv-
ered to the upper epithelia of the experimental animal's shaved
abdominal skin using the Helios Gene Gun (BioRad, Germany)
driven by helium at a pressure of 300 psi. Each of the three shots
at separate positions delivered approximately 1 mg DNA.
Infection with virus was achieved by intraperitoneal injection
of 1 ml of cell-free culture supernatant containing 106/ml infec-
tious PFV/SFVmac particles into anaesthetised animals (Isoﬂuran).
Blood samples were then taken at regular intervals and serum
stored at -20 1C.
Organ preparation, isolation of genomic DNA and virus re-isolation
Samples of spleen, lung, tongue, liver, lymph node, intestine
and blood were taken from the euthanised animals at the end of
the experiment. PBMC were isolated by density gradient centrifu-
gation of whole blood using Histopaques-1077 (Sigma-Aldrich,
Germany). Plasma was collected and stored at 20 1C. DNA was
isolated from all organs by cell lysis, phenol/chloroform/isoamyl
alcohol extraction and ethanol precipitation according to standard
procedures (Sambrook et al., 1989). The quantity and purity of the
isolated DNA was determined photometrically at 260 nm and
280 nm. Single cell suspensions from the lungs and spleens were
also prepared and co-cultivated (5106 cells) with MRC-5 cells
without stimulation. After ﬁve days, the primary cells were
removed and the MRC-5 cells cultivated further for three weeks.
Saliva samples were obtained from all animals by washing the oral
cavity twice with 2 ml PBS. These were then centrifuged and cell-
free supernatant added to MRC-5 cells together with 5 mg/ml
Ciproﬂoxacin and also incubated for four weeks. Infection was
detected by microscopic observation and by PCR. Virus re-isolation
from hamster and mouse organs was achieved by co-cultivating
single cell suspensions with MRC-5 cells in an equal mix of RPMI
and MEM containing 10% FCS, 1% penicillin/streptomycin, 1 mM
sodium pyruvate and 1 mM L-glutamine.
Immunoblotting and enzyme-linked immunosorbent assay (ELISA)
SDS-PAGE and semidry western blotting were performed using
standard protocols with lysates of infected BHK-21 cells as antigen
and sera diluted 1:750 to 1:1000 (hamsters), 1:250 (mice) or
1:1500 from a naturally infected rhesus macaque. ELISAs were also
performed using standard protocols (Perkovic et al., 2010) with
infected BHK-21 cell lysates to coat plates and sera diluted in
three-fold steps from 1:20 to 1:43,740. Titres were calculated as
the dilution at which the line of best ﬁt crossed the cut-off
OD (0.2).
Neutalisation assay
BHK21 cells were seeded into microtitre plates in 100 ml
medium (DMEM-10% FCS) and allowed to attach and grow over-
night. 20 ml of sera to be tested (undiluted or diluted 1:2 in
medium) were mixed with 80 ml of virus-containing cell super-
natant (5104 infectious particles/ml) and incubated for 20 min
at 37 1C. The mixtures were then added to the BHK21 cells (to give
ﬁnal dilutions of sera in the wells of 1:10 and 1:20). After a further
72 h incubation, supernatants were removed, the cells lysed and
the levels of viral DNA measured by real time PCR (Behrendt et al.,
2009). Neutralisation (NT) was expressed as n-fold reduction in
viral DNA as calculated by: NT¼2ΔCT.
Real-time PCR-based detection of proviral DNA
A nested PCR using a generic foamy virus FAM-probe was
established to facilitate detection of PFV and SFVmac-R289-
hybAGM proviral DNA. The probe (5'-FAM-TTGGAATTCAGTAC-
TCCTTATCACCC-BHQ1-3') allows most species of the foamy virus
family to be detected as it binds to a highly conserved region of the
pol gene. Appropriate primers ﬂanking the probe were generated
to allow speciﬁc detection of different subtypes. For PFV, the outer
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primers giving a 482 bp product were 1Nes-F17-for (50-GGTTA-
TACCCCACTAAGGCTCCTTCTACTAGCGC -30) and 1Nes-R18rev
(5′-GGAACGAGAGGAGGCTGGAGGGGTGGATGG-30) and the inner
primers giving a 209 bp product were PFV-F1for (5′-CTTCAA-
CCTTTGCTGAATG-30) and PFV-R3rev (50-TAATACAGGGCTATAGG-
TGT-30) (Mullers et al., 2011). For SFVmac-R289hybAGM the
outer primers giving a 403 bp product were RH6-NesOut-for
(50-GGCTCCCTCAACTAGCGCAACTGTTAAAGCTCTC-30) and RH6-
NesOut2-rev (50-GAGACAACTCCTCTTCTCTGGATAAATCAAGTGTAT-
CAG-30) and the inner primers giving a 257 bp product were
RH6-NesIn-for (50-CTACTTTTGCTGATTGGGC-30) and RH6-NesIn-
rev (50-CAAACGGTGTGTTGGAATC-30). The ﬁrst reaction using
1 mg genomic DNA (approximately equivalent to 1.6105 cells)
as template was carried out with 95 1C/10 min pre-denaturation
and 25 cycles of 95 1C/30 s to 67 1C/30 s to 72 1C/40 s. The second,
nested real-time PCR using the generic FAM-probe was performed
with 95 1C/10 min pre-denaturation followed by 50 cycles of 95 1C/
30 s to 58 1C/30 s to 72 1C/20 s. Highly diluted genomic DNA from
infected BHK-21 cells spiked with 1 mg genomic DNA from unin-
fected BKH-21 cells was used as positive control. Due to initial
problems with DNA contamination encountered during the estab-
lishment of the nested PCR system, all organ preparations and
PCRs were carried out under ‘diagnostic’ conditions. Dilutions of a
plasmid standard indicated a detection limit of 5 copies per
microgram DNA. We also developed a real time primer set for
the feline foamy virus strain pCF-7 in the pol region named
FFV-real-for (50-CTGAAGAATTTGCTCAGTG-30) and FFV-real-rev
(50-TACTTGGTGCTGACAACAT-30). For this assay, the newly devel-
oped generic probe can also be used.
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